Maintenance of the viral episome is essential for the cell survival of an Epstein-Barr virus positive gastric carcinoma cell line

[1]  He Dan,et al.  Suppression of EBNA1 expression inhibits growth of EBV-positive NK/T cell lymphoma cells , 2008, Cancer biology & therapy.

[2]  Dong-jik Shin,et al.  Establishment and characterization of an in vivo model for Epstein–Barr virus positive gastric carcinoma , 2007, Journal of medical virology.

[3]  Xiaoling Li,et al.  Epstein-Barr virus integrates frequently into chromosome 4q, 2q, 1q and 7q of Burkitt's lymphoma cell line (Raji). , 2006, Journal of virological methods.

[4]  E. Flemington,et al.  siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells. , 2006, Virology.

[5]  D. Huntsman,et al.  Gastric cancer: New genetic developments , 2005, Journal of surgical oncology.

[6]  K. Tsuneyama,et al.  Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt’s lymphoma cells , 2005, Journal of Cancer Research and Clinical Oncology.

[7]  Y. Satoh,et al.  Mechanism for induction of hydroxyurea resistance and loss of latent EBV genome in hydroxyurea‐treated Burkitt's lymphoma cell line Raji , 2004, Journal of medical virology.

[8]  Dong-jik Shin,et al.  A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. , 2004, Virology.

[9]  H. Kung,et al.  Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells. , 2004, Biochemical and biophysical research communications.

[10]  A. Hengstermann,et al.  siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells , 2003, Oncogene.

[11]  M. Fukuda,et al.  Contrasting effects of hydroxyurea on cell growth and reduction in Epstein‐Barr virus genomes in EBV‐infected epithelioid cell lines vs. Burkitt's lymphoma cell lines , 2003, Journal of medical virology.

[12]  D. Dykxhoorn,et al.  Killing the messenger: short RNAs that silence gene expression , 2003, Nature Reviews Molecular Cell Biology.

[13]  K. Alexander,et al.  RNA Interference of Human Papillomavirus Type 18 E6 and E7 Induces Senescence in HeLa Cells , 2003, Journal of Virology.

[14]  E. Bloemena,et al.  A Rapid and Reliable Enzyme Immunoassay PCR-Based Screening Method to Identify EBV-Carrying Gastric Carcinomas , 2002, Modern Pathology.

[15]  A. Rickinson.  Epstein-Barr virus. , 2001, Virus research.

[16]  P. Furth,et al.  Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system , 2000, The Lancet.

[17]  K. Takada.  Epstein-Barr virus and gastric carcinoma , 2000, Molecular pathology : MP.

[18]  L. Young,et al.  The expression and function of Epstein-Barr virus encoded latent genes , 2000, Molecular pathology : MP.

[19]  K. Kawa,et al.  Epstein-Barr virus--associated diseases in humans. , 2000, International journal of hematology.

[20]  M. Okano,et al.  A review of Epstein-Barr virus infection in patients with immunodeficiency disorders. , 2000, The American journal of the medical sciences.

[21]  J. Yates,et al.  Genetic Evidence that EBNA-1 Is Needed for Efficient, Stable Latent Infection by Epstein-Barr Virus , 1999, Journal of Virology.

[22]  K. Takada,et al.  Epstein-Barr Virus Contributes to the Malignant Phenotype and to Apoptosis Resistance in Burkitt’s Lymphoma Cell Line Akata , 1998, Journal of Virology.

[23]  J. Sample,et al.  Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype. , 1998, The Journal of infectious diseases.

[24]  Y. Bang,et al.  Establishment and characterization of human gastric carcinoma cell lines , 1997, International journal of cancer.

[25]  K. Takada,et al.  Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV , 1994, Journal of virology.

[26]  M. Gulley,et al.  Epstein‐barr virus integration in human lymphomas and lymphoid cell lines , 1992, Cancer.

[27]  D. Shibata,et al.  Epstein-Barr virus-associated gastric adenocarcinoma. , 1992, The American journal of pathology.

[28]  L. Sobin,et al.  Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[29]  J. Lawrence,et al.  Sensitive, high-resolution chromatin and chromosome mapping in situ: Presence and orientation of two closely integrated copies of EBV in a lymphoma line , 1988, Cell.

[30]  C. Mettlin.  Levels of epidemiologic proof in studies of diet and cancer with special reference to dietary fat and vitamin A. , 1988, Progress in clinical and biological research.

[31]  E. Kieff,et al.  Repeat arrays in cellular DNA related to the Epstein-Barr virus IR3 repeat , 1985, Molecular and cellular biology.

[32]  E. Kieff,et al.  Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA. , 1984, Science.

[33]  A. Gräslund,et al.  Characterization of the free radical of mammalian ribonucleotide reductase. , 1982, The Journal of biological chemistry.